American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

Gastroenterology. 2013 Dec;145(6):1459-63. doi: 10.1053/j.gastro.2013.10.047.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Azathioprine / therapeutic use*
  • Crohn Disease / drug therapy*
  • Gastroenterology
  • Humans
  • Mercaptopurine / therapeutic use*
  • Methotrexate / therapeutic use*
  • Remission Induction
  • Societies, Medical
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • United States

Substances

  • Tumor Necrosis Factor-alpha
  • Mercaptopurine
  • Azathioprine
  • Methotrexate